Nelarabine and optimisation of therapy for T-cell acute lymphoblastic leukaemia
Affiliation
Paediatric Haematology and Oncology, Tata Medical Center, Kolkata, IndiaIssue Date
2023
Metadata
Show full item recordAbstract
NoneCitation
Ghara N, Saha V. Nelarabine and optimisation of therapy for T-cell acute lymphoblastic leukaemia. The Lancet Haematology. 2023 May 8. PubMed PMID: 37167993. Epub 2023/05/12. eng.Journal
Lancet HaematologyDOI
10.1016/s2352-3026(23)00091-1PubMed ID
37167993Additional Links
https://dx.doi.org/10.1016/s2352-3026(23)00091-1Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/s2352-3026(23)00091-1